Suppr超能文献

表面置换与传统全髋关节置换术后异位骨化的发生率:采用前外侧入路和吲哚美辛预防的对比研究。

Incidence of heterotopic ossification after surface and conventional total hip arthroplasty: a comparative study using anterolateral approach and indomethacin prophylaxis.

机构信息

Department of Orthopaedic Surgery, Azienda Ospedaliera Universitaria Integrata, Piazzale A Stefani 1, 37126 Verona, Italy.

出版信息

Biomed Res Int. 2013;2013:293528. doi: 10.1155/2013/293528. Epub 2013 Jun 24.

Abstract

The incidence and severity of heterotopic ossification (HO) in two homogeneous groups of patients that received surface replacement arthroplasty (SRA) and conventional total hip arthroplasty (THA) were evaluated retrospectively. Thirty-nine patients undergoing 42 hip resurfacing procedures and 41 primary cementless THAs through an anterolateral approach received a 10-day course of 150 mg/die of indomethacin postoperatively. The median surgical time was 190 minutes and 156 minutes, respectively (P < 0.003). At a minimum 1-year followup, the development of HO was assessed on standard X-ray using Brooker grading. Ectopic bone formation was detected in five cases (11.9%, two Brooker grade I and three grade II) in the SRA group and in 14 hips (34.1%, 12 grade I and two grade II) treated with conventional THA, but the difference was not significant (P < 0.11). No clinically relevant periprosthetic ossification (Brooker III or IV) occurred in both groups. Although the difference was not statistically significant, the incidence of HO after SRA was lower than conventional THA. More extensive soft tissue trauma, bone debris, and longer operative time in hip resurfacing are not likely to be absolute risk factors for HO. Further investigations including larger patient populations are needed to confirm these findings.

摘要

回顾性评估了接受表面置换关节成形术(SRA)和传统全髋关节置换术(THA)的两组同质患者中异位骨化(HO)的发生率和严重程度。42 例髋关节表面置换术和 41 例经前外侧入路行初次非骨水泥 THA 的患者,术后均接受 10 天 150mg/die 的吲哚美辛治疗。中位手术时间分别为 190 分钟和 156 分钟(P<0.003)。在至少 1 年的随访中,使用布鲁克分级标准在标准 X 线上评估 HO 的发展情况。在 SRA 组中,有 5 例(11.9%,2 例布鲁克 I 级和 3 例 II 级)和在接受传统 THA 治疗的 14 髋中(34.1%,12 例 I 级和 2 例 II 级)检测到异位骨形成,但差异无统计学意义(P<0.11)。两组均未发生临床相关的假体周围骨化(布鲁克 III 或 IV 级)。尽管差异无统计学意义,但 SRA 后 HO 的发生率低于传统 THA。髋关节表面置换术软组织创伤更广泛、骨屑更多和手术时间更长不太可能是 HO 的绝对危险因素。需要进一步包括更大患者群体的研究来证实这些发现。

相似文献

2
Aspirin decreases heterotopic ossification after hip resurfacing.
Clin Orthop Relat Res. 2011 Jun;469(6):1614-20. doi: 10.1007/s11999-011-1846-6.
6
The incidence of heterotopic ossification after hip arthroscopy.
Am J Sports Med. 2012 Apr;40(4):854-63. doi: 10.1177/0363546511434285. Epub 2012 Jan 20.
8
Low rates of heterotopic ossification after resurfacing hip arthroplasty with use of prophylactic radiotherapy in select patients.
J Arthroplasty. 2012 Aug;27(7):1349-53. doi: 10.1016/j.arth.2011.11.017. Epub 2012 Jan 14.
9
Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty.
Arch Orthop Trauma Surg. 2003 Apr;123(2-3):91-4. doi: 10.1007/s00402-003-0487-y. Epub 2003 Mar 28.

引用本文的文献

1
Challenges and advances in the management of heterotopic ossification in total hip arthroplasty.
Bone Joint Res. 2025 Apr 16;14(4):351-355. doi: 10.1302/2046-3758.144.BJR-2024-0323.R1.
2
Severe heterotopic ossification after total hip arthroplasty in male patients under 70 years of age: effectiveness of prophylactic protocol.
Musculoskelet Surg. 2025 Jun;109(2):201-205. doi: 10.1007/s12306-024-00868-4. Epub 2024 Oct 9.
3
Acetabular Reaming Is a Reliable Model to Produce and Characterize Periarticular Heterotopic Ossification of the Hip.
Stem Cells Transl Med. 2022 Aug 23;11(8):876-888. doi: 10.1093/stcltm/szac042.
4
Heterotopic ossification in primary total hip arthroplasty: risk factor analysis.
Eur J Orthop Surg Traumatol. 2023 May;33(4):1037-1041. doi: 10.1007/s00590-022-03244-9. Epub 2022 Mar 19.
5
Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signaling.
Nat Metab. 2019 Jan;1(1):111-124. doi: 10.1038/s42255-018-0005-8. Epub 2019 Jan 7.
6
Heterotopic Ossification: Basic-Science Principles and Clinical Correlates.
J Bone Joint Surg Am. 2015 Jul 1;97(13):1101-11. doi: 10.2106/JBJS.N.01056.

本文引用的文献

1
Risk factors for heterotopic ossification in primary total hip arthroplasty.
Hip Int. 2012 Jan-Feb;22(1):50-5. doi: 10.5301/HIP.2012.9057.
2
Heterotopic bone formation following resurfacing total hip arthroplasty.
HSS J. 2011 Feb;7(1):41-3. doi: 10.1007/s11420-010-9163-2. Epub 2010 Apr 21.
3
Aspirin decreases heterotopic ossification after hip resurfacing.
Clin Orthop Relat Res. 2011 Jun;469(6):1614-20. doi: 10.1007/s11999-011-1846-6.
4
Heterotopic ossifications following implant surgery--epidemiology, therapeutical approaches and current concepts.
Semin Immunopathol. 2011 May;33(3):273-86. doi: 10.1007/s00281-011-0240-5. Epub 2011 Jan 16.
5
The clinical and radiological outcomes of hip resurfacing versus total hip arthroplasty: a meta-analysis and systematic review.
Acta Orthop. 2010 Dec;81(6):684-95. doi: 10.3109/17453674.2010.533933. Epub 2010 Nov 11.
6
Does a plastic drape reduce incidence of heterotopic ossification after hip resurfacing?
Clin Orthop Relat Res. 2011 Jun;469(6):1606-13. doi: 10.1007/s11999-010-1606-z.
7
Heterotopic ossification after surface replacement arthroplasty and total hip arthroplasty: a randomized study.
J Arthroplasty. 2009 Feb;24(2):256-62. doi: 10.1016/j.arth.2007.12.004. Epub 2008 Apr 11.
9
Incidence of heterotopic ossification after hip resurfacing.
ANZ J Surg. 2007 Aug;77(8):642-7. doi: 10.1111/j.1445-2197.2007.04178.x.
10
The prophylaxis and treatment of heterotopic ossification following lower limb arthroplasty.
J Bone Joint Surg Br. 2007 Apr;89(4):434-40. doi: 10.1302/0301-620X.89B4.18845.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验